Recurrence of sarcoidosis after heart and lung transplantation: a retrospective single-center cohort study

Clicks: 16
ID: 331913
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #228 of 339 articles by views in Lara D. Veeken

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 339 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives To determine the incidence of sarcoidosis recurrence following heart or lung transplantation and to characterize recurrence patterns and clinical features in a single-center cohort. Methods We conducted a retrospective cohort study using the Stanford Medicine Research Data Repository from 2008-2022. Adult patients with pulmonary or cardiac sarcoidosis who underwent lung or heart transplantation were identified using International Classification of Diseases codes and confirmed by manual chart review. Clinical characteristics, treatment history, and outcomes were extracted. The primary outcome was recurrence of sarcoidosis in the transplanted organ. Secondary outcomes included recurrence in non-transplanted organs, graft loss, rejection, and mortality. Time-to-recurrence was evaluated using Kaplan–Meier analysis. Results Fifty-eight sarcoidosis patients met inclusion criteria (22 pulmonary, 36 cardiac). Recurrence in the transplanted organ occurred in 7 of 58 patients (12.1%): 1 of 22 lung transplant recipients (4.5%) and 6 of 36 heart transplant recipients (16.7%). Recurrence in non-transplanted organs occurred in 1 pulmonary recipient (4.5%) and 5 cardiac recipients (13.9%). One cardiac recipient experienced recurrence in both transplanted and extra-transplant sites. Among heart transplant recipients, patients with recurrence were older (mean 60.8 vs. 55.2 years), whereas comorbidities, pre-transplant therapies, and post-transplant immunosuppressive regimens were similar. Mean follow-up was 5.7 vs 6.2 years for pulmonary and cardiac recipients respectively. Conclusion Sarcoidosis recurrence occurred after both lung and heart transplantation and was more common after heart transplantation in this cohort. Recurrence despite standard immunosuppression supports ongoing surveillance and further study of recurrence mechanisms and prevention strategies.
Reference Key
openalex_W7221098191 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Samantha Pickell, Lakshmi Jayaram, 刘玉含, Matthew Baker
Are you one of these authors? Claim your profile
Journal Lara D. Veeken
Year 2026
DOI
10.1093/rheumatology/keag567
URL
https://doi.org/10.1093/rheumatology/keag567
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.